Monocyte Chemoattractant Protein‐1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · see citing works

Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease

Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · see citing works

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915 · see citing works

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S.-H. C., & Brosnan, C. F. (1993) · Glia · doi:10.1002/glia.440070113 · Cited by 821 · see citing works

Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices

Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483 · see citing works

Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms

Sastre, M., Klockgether, T., & Heneka, M. T. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.014 · Cited by 426 · see citing works

Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro

Lue, L., Rydel, R. E., Brigham, E. F., Yang, L., Hampel, H. J., Murphy, G. M., Brachova, L., Yan, S., Walker, D. G., Shen, Y., et al. (2001) · Glia · doi:10.1002/glia.1072 · Cited by 382 · see citing works

Inflammation and neurodegenerative diseases

Griffin, W. S. T. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.470s · Cited by 351 · see citing works

A Gene Expression Profile of Alzheimer's Disease

Loring, J. F., Wen, X., Lee, J. M., Seilhamer, J. J., & Somogyi, R. (2001) · DNA and Cell Biology · doi:10.1089/10445490152717541 · Cited by 300 · see citing works

Inflammatory factors are elevated in brain microvessels in Alzheimer's disease

Grammas, P. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00276-7 · Cited by 292 · see citing works

Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease

Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M. A., Bresolin, N., & Scarpini, E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.538 · Cited by 289 · see citing works

The expression and function of chemokines involved in CNS inflammation

Ubogu, E. E., Cossoy, M. B., & Ransohoff, R. M. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.002 · Cited by 277 · see citing works

Immunohistochemical Study of the β-Chemokine Receptors CCR3 and CCR5 and Their Ligands in Normal and Alzheimer's Disease Brains

Xia, M., Qin, S., Wu, L.-J., Mackay, C., & Hyman, B. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65542-3 · Cited by 267 · see citing works

Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice

Janelsins, M. C., Mastrangelo, M. A., Oddo, S., LaFerla, F. M., Federoff, H. J., & Bowers, W. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-23 · Cited by 260 · see citing works

Identification of monocyte chemoattractant protein‐1 in senile plaques and reactive microglia of Alzheimer's disease

ISHIZUKA, K., KIMURA, T., IGATA‐YI, R., KATSURAGI, S., TAKAMATSU, J., & MIYAKAWA, T. (1997) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1997.tb02375.x · Cited by 245 · see citing works

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein

Wood, J. A., Wood, P. L., Ryan, R., Graff-Radford, N. R., Pilapil, C., Robitaille, Y., & Quirion, R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91327-o · Cited by 244 · see citing works

Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis

Tanuma, N., Sakuma, H., Sasaki, A., & Matsumoto, Y. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0083-7 · Cited by 237 · see citing works

Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients

Huell, M., Strauss, S., Volk, B., Berger, M., & Bauer, J. (1995) · Acta Neuropathologica · doi:10.1007/bf00571510 · Cited by 214 · see citing works

Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease

Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mariani, C., Bresolin, N., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.007 · Cited by 209 · see citing works

Inflammatory changes parallel the early stages of Alzheimer disease

Parachikova, A., Agadjanyan, M. G., Cribbs, D. H., Blurton-Jones, M., Perreau, V., Rogers, J., Beach, T. G., & Cotman, C. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.014 · Cited by 203 · see citing works

Mechanisms of Cell Signaling and Inflammation in Alzheimers Disease

Ho, G. J., Drego, R., Hakimian, E., & Masliah, E. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010053586237 · Cited by 199 · see citing works

Cytokine Gene Expression as a Function of the Clinical Progression of Alzheimer Disease Dementia

Luterman, J. D., Haroutunian, V., Yemul, S., Ho, L., Purohit, D., Aisen, P. S., Mohs, R., & Pasinetti, G. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.8.1153 · Cited by 192 · see citing works

Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344

Brodmerkel, C. M., Huber, R., Covington, M. B., Diamond, S., Hall, L. M., Collins, R. J., Leffet, L., Gallagher, K., Feldman, P., Collier, P., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5370 · Cited by 186 · see citing works

Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.

Cacabelos, R., Alvarez, X. A., Fernández‐Novoa, L., Franco, A., Mangues, R., Pellicer, À., & Nishimura, T. (1994) · PubMed · Cited by 182 · see citing works

Neuronal Chemokines: Versatile Messengers In Central Nervous System Cell Interaction

Haas, A. H. D., van Weering, H. R. J., de Jong, E. K., Boddeke, H. W. G. M., & Biber, K. P. H. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0036-8 · Cited by 182 · see citing works

The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS

Henkel-Tigges, J., Beers, D. R., Siklós, L., & Appel, S. H. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.10.016 · Cited by 181 · see citing works

Longitudinal Study of Inflammatory Factors in Serum, Cerebrospinal Fluid, and Brain Tissue in Alzheimer Disease

Lanzrein, A.-S., Johnston, C., Perry, V. H., Jobst, K. A., King, E. M., & Smith, A. D. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00016 · Cited by 178 · see citing works

Two novel (M233T and ρ278T) presenilin-1 mutations in early-onset Alzheimerʼs disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype

Kwok, J. B., Taddei, K., Hallupp, M., Fisher, C., Brooks, W. S., Broe, G. A., Hardy, J., FULHAM, M. J., Nicholson, G. A., Stell, R., et al. (1997) · Neuroreport · doi:10.1097/00001756-199704140-00043 · Cited by 160 · see citing works

Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease

Sheng, J. G., Mrak, R. E., Rovnaghi, C. R., Kozłowska, E., Eldik, L. J. V., & Griffin, W. S. T. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00037-1 · Cited by 156 · see citing works

Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia

Walker, D. G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00306-2 · Cited by 154 · see citing works

The Induction of the TNFα Death Domain Signaling Pathway in Alzheimer's Disease Brain

Zhao, M., Cribbs, D. H., Anderson, A. J., Cummings, B. J., Su, J. H., Wasserman, A., & Cotman, C. W. (2003) · Neurochemical Research · doi:10.1023/a:1022337519035 · Cited by 149 · see citing works

Overexpression of Monocyte Chemotactic Protein-1/CCL2 in β-Amyloid Precursor Protein Transgenic Mice Show Accelerated Diffuse β-Amyloid Deposition

Yamamoto, M., Horiba, M., Buescher, J. L., Huang, D., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62364-4 · Cited by 137 · see citing works

Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease.

Xia, M., Qin, S., McNamara, M. J., Mackay, C. R., & Hyman, B. T. (1997) · Europe PMC (PubMed Central) · Cited by 131 · see citing works

The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain

Gómez‐Isla, T., Growdon, W. B., McNamara, M. J., Nochlin, D., Bird, T. D., Arango, J. C., Lopera, F., Kosik, K. S., Lantos, P. L., Cairns, N. J., et al. (1999) · Brain · doi:10.1093/brain/122.9.1709 · Cited by 128 · see citing works

Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: Selective effects on specific interleukins and interleukin receptors

Araujo, D. M., & Lapchak, P. A. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90398-0 · Cited by 113 · see citing works

In vivo imaging of neuroinflammation

Cagnin, A. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00107-4 · Cited by 110 · see citing works

Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues

Weeraratna, A. T., Kalehua, A. N., DeLeon, I., Bertak, D., Maher, G., Wade, M. S., Lustig, A., Becker, K. G., Wood, W. W., Walker, D. G., et al. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.028 · Cited by 109 · see citing works

Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load

Pulliam, L., Sun, B., & Rempel, H. C. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.08.039 · Cited by 103 · see citing works

Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue

Hulse, R. E., Kunkler, P. E., Fedynyshyn, J., & Kraig, R. P. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2003.12.023 · Cited by 93 · see citing works

Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo

Szczepanik, A. M., Rampe, D., & Ringheim, G. E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00240.x · Cited by 87 · see citing works

Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES

Matsui, M., Weaver, J. T., Proudfoot, A. E. I., Wujek, J. R., Wei, T., Richer, E., Trapp, B. D., Rao, A., & Ransohoff, R. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00121-2 · Cited by 78 · see citing works

Cortical Inflammation in Alzheimer Disease but Not Dementia With Lewy Bodies

Shepherd, C. E., Thiel, E., McCann, H., Harding, A. J., & Halliday, G. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.817 · Cited by 67 · see citing works

The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation

Ferreira, A. M., Rollins, B. J., Faunce, D. E., Burns, A. L., Zhu, X., & DiPietro, L. A. (2005) · Cytokine · doi:10.1016/j.cyto.2004.12.006 · Cited by 49 · see citing works

Neurofilament-Immunoreactive Neurons in Alzheimer's Disease and Dementia with Lewy Bodies

Shepherd, C. E., McCann, H., Thiel, E., & Halliday, G. M. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0469 · Cited by 47 · see citing works

Preliminary studies on Alzheimer's disease using cDNA microarrays

Wang, G., Zhang, Y., Chen, B., & Cheng, J. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00188-4 · Cited by 41 · see citing works

Differences in regional brain atrophy in genetic forms of Alzheimer's disease

Gregory, G. C., Macdonald, V., Schofield, P. R., Kril, J. J., & Halliday, G. M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.011 · Cited by 36 · see citing works

Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques

Shepherd, C. E., Gregory, G. C., Vickers, J. C., Brooks, W. S., Kwok, J. B., Schofield, P. R., Kril, J. J., & Halliday, G. M. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.10.008 · Cited by 35 · see citing works

Distribution of ICAM-1 immunoreactivity during aging in the human orbitofrontal cortex

Miguel-Hidalgo, J. J., Nithuairisg, S., Stockmeier, C. A., & Rajkowska, G. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.05.001 · Cited by 33 · see citing works

Inflammatory Mediators in the Frontal Lobe of Patients with Mixed and Vascular Dementia

Mulugeta, E., Molina‐Holgado, F., Elliott, M. S. J., Hortobágyi, T., Perry, R., Kalaria, R. N., Ballard, C. G., & Francis, P. T. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000118633 · Cited by 29 · see citing works

Novel ‘inflammatory plaque’ pathology in presenilin‐1 Alzheimer's disease

Shepherd, C. E., Gregory, G. C., Vickers, J. C., et al. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00667.x · Cited by 22 · see citing works

Relationship between neuronal loss and ‘inflammatory plaques’ in early onset Alzheimer's disease

Shepherd, C. E., Grace, E. M., Mann, D. M. A., & Halliday, G. M. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00816.x · Cited by 14 · see citing works

Neuroinflammation: The Devil Is in the Details

DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640 · see citing works

Tau and neuroinflammation: what impact for Alzheimer's disease and tauopathies?

Laurent, C., Buée, L., & Blum, D. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.01.003 · Cited by 348 · see citing works

Massive gliosis induced by interleukin‐6 suppresses Aβ deposition <i>in vivo:</i> evidence against inflammation as a driving force for amyloid deposition

Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., & Das, P. (2010) · The FASEB Journal · doi:10.1096/fj.09-141754 · Cited by 328 · see citing works

Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype: Astrocyte senescence in aging brain

Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07738.x · Cited by 333 · see citing works

Cellular senescence in brain aging

Sikora, E., Bielak-Zmijewska, A., Dudkowska, M., Krzystyniak, A., Mosieniak, G., Wesierska, M., & Wlodarczyk, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646924 · Cited by 304 · see citing works

Oxidative stress and β-amyloid protein in Alzheimer’s disease

Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279 · see citing works

CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease

Westin, K., Buchhave, P., Nielsen, H., Minthon, L., Janciauskiene, S., & Hansson, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030525 · Cited by 277 · see citing works

Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases

Spielman, L. J., Gibson, D. L., & Klegeris, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.005 · Cited by 266 · see citing works

Hippocampal Astrocyte Cultures from Adult and Aged Rats Reproduce Changes in Glial Functionality Observed in the Aging Brain

Bellaver, B., Souza, D. G., Souza, D. O., & Quincozes-Santos, A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9880-8 · Cited by 135 · see citing works

Microglia in Aging and Alzheimer’s Disease: A Comparative Species Review

Edler, M. K., Mhatre-Winters, I., & Richardson, J. R. (2021) · Cells · doi:10.3390/cells10051138 · Cited by 126 · see citing works

From cellular senescence to Alzheimer’s disease: The role of telomere shortening

Boccardi, V., Pelini, L., Ercolani, S., Ruggiero, C., & Mecocci, P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.003 · Cited by 121 · see citing works

Mechanisms of Mononuclear Phagocyte Recruitment in Alzheimers Disease

Hickman, S. E., & Khoury, J. E. (2010) · CNS &amp; Neurological Disorders - Drug Targets · doi:10.2174/187152710791011982 · Cited by 120 · see citing works

Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain

Welikovitch, L. A., Do Carmo, S., Maglóczky, Z., Malcolm, J. C., Lőke, J., Klein, W. L., Freund, T., & Cuello, A. C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914593117 · Cited by 116 · see citing works

Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies

Guedes, J. R., Lao, T., Cardoso, A. L., & El Khoury, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00549 · Cited by 115 · see citing works

Binding and uptake of Aβ1‐42 by primary human astrocytes <i>in vitro</i>

Nielsen, H. M., Veerhuis, R., Holmqvist, B., & Janciauskiene, S. (2009) · Glia · doi:10.1002/glia.20822 · Cited by 96 · see citing works

Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer’s and other neurodegenerative diseases

Golde, T. E., & Miller, V. M. (2009) · Alzheimer's Research &amp; Therapy · doi:10.1186/alzrt5 · Cited by 98 · see citing works

Role of Chemokines in the Development and Progression of Alzheimer’s Disease

Wojcieszak, J., Kuczyńska, K., & Zawilska, J. B. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02047-1 · Cited by 97 · see citing works

The Therapeutic Role of Minocycline in Parkinson’s Disease

Cankaya, S., Cankaya, B., Kilic, U., Kilic, E., & Yulug, B. (2019) · Drugs in Context · doi:10.7573/dic.212553 · Cited by 93 · see citing works

Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration

Welch, G. M., Boix, C. A., Schmauch, E., Davila-Velderrain, J., Victor, M. B., Dileep, V., Bozzelli, P. L., Su, Q., Cheng, J. D., Lee, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo4662 · Cited by 84 · see citing works

Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease

Lalli, M. A., Bettcher, B. M., Arcila, M. L., Garcia, G., Guzman, C., Madrigal, L., Ramirez, L., Acosta-Uribe, J., Baena, A., Wojta, K. J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.131 · Cited by 73 · see citing works

Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation

Malm, T., Mariani, M., Donovan, L. J., Neilson, L., & Landreth, G. E. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0229-9 · Cited by 77 · see citing works

Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs

Chung, M.-M., Nicol, C. J., Cheng, Y.-C., Lin, K.-H., Chen, Y.-L., Pei, D., Lin, C.-H., Shih, Y.-N., Yen, C.-H., Chen, S.-J., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.01.017 · Cited by 66 · see citing works

MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease

Michaud, J.-P., Richard, K. L., & Rivest, S. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-5 · Cited by 48 · see citing works

Dietary intervention with edible medicinal plants and derived products for prevention of Alzheimer's disease: A compendium of time-tested strategy

Peng, Y., Tao, H., Wang, S., Xiao, J., Wang, Y., & Su, H. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104463 · Cited by 31 · see citing works

Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer’s Disease Patients from Healthy Subjects

Hochstrasser, T., Marksteiner, J., Defrancesco, M., Deisenhammer, E. A., Kemmler, G., & Humpel, C. (2011) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000330468 · Cited by 31 · see citing works

IL-17–Mediated Monocyte Migration Occurs Partially through CC Chemokine Ligand 2/Monocyte Chemoattractant Protein-1 Induction

Shahrara, S., Pickens, S. R., Mandelin, A. M., Karpus, W. J., Huang, Q., Kolls, J. K., & Pope, R. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901942 · Cited by 150 · see citing works

Monocyte chemotactic and activating factor (MCAFMCP-1) has an autoinductive effect in monocytes, a process regulated by IL-10

Vestergaard, C., Gesser, B., Lohse, N., Jensen, S. L., Sindet‐Pedersen, S., Thestrup‐Pedersen, K., Matsushima, K., & Grønhøj, C. (1997) · Journal of Dermatological Science · doi:10.1016/s0923-1811(96)00589-0 · Cited by 24 · see citing works

Changes in the Profiles of Chemokines Secreted by Endothelial Cells and Monocytes under Different Coculturing Conditions

Starickova, E. A., Соколов, Д. И., Selkov, S. А., et al. (2011) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-011-1165-7 · Cited by 5 · see citing works

Multinucleate giant cells and the control of chemokine secretion in response to Mycobacterium tuberculosis

Zhu, X. W., & Friedland, J. S. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.009 · Cited by 39 · see citing works

Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells

Haberstroh, U., Pocock, J., Gómez‐Guerrero, C., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00572.x